INDIAN AIR FORCEINDIAN ARMYINDIAN NAVY

Defence Minister Rajnath Singh approves Revision of Medical Schedules of Powers (MSP -2022) to Armed Forces Medical Services

New Delhi, August 3. Defence Minister Rajnath Singh has approved the order on Medical Schedules of Powers 2022 (MSP-2022), enhancing the financial powers delegated to Armed Forces Medical Services (AFMS). MSP – 2022 has been notified by Ministry of Defence on 1st Aug 2022. The enhanced delegation of Financial Powers to functionaries in Headquarters and lower formations would lead to quicker decision making at all levels resulting in better planning and operational preparedness of the AFMS. It would also endure the optimal utilisation of resources.

The primary objective of the enhanced delegation of financial powers is to empower Competent Financial Authorities (CFA) at Hospitals and below for procurement in Medical stores in an efficient manner for urgent operational necessities and meeting essential medical requirements. It aims to empower hospitals and field formations and focus on operational preparedness. It will also promote ease of doing business, enhancing the delivery of healthcare.

It may be recalled that enhancement of delegation of financial power at all levels for the Medical Services was done in 2016. MSP – 2022 will help to overcome procedural delays and also bring about greater decentralisation and operational efficiency.

 Followings are Key Highlights of MSP-2022:

  • Devolution of financial powers to Field Units, Hospitals:  Focus on enhancing pace and quality of healthcare delivery thereby enhancing operational preparedness.
  • Two times general enhancement of delegated powers for Competent Financial Authorities and up to 3 – 10 times enhancement at field formations in certain Schedules on account of operational requirements.
  • Impetus for Clinical Studies, Research and Development: In line with the Atmanirbhar Bharat initiative, Substantial enhancement up to three times the existing powers has been approved in the Schedules related to Clinical Studies, Research & Development.

Related Articles

Back to top button